All of our data suggest that ECM1a plays a tumorigenic role and confers cancer cell cisplatin resistance through integrin αXβ2/hnRNPLL/ABCG1-mediated cellular phosphorylation signaling and stemness induction. This evidence concerns the gene ABCG1 and cancer.